Sollis

Therapeutics

About Us
Development Program
- About Sciatica
- Clinical Trials
Products
Careers
News
Contact Us

cropped-logomark.png

http://sollis.ingedesign.com/wp-content/uploads/2017/06/cropped-logomark.png

cropped-logomark.png

← Previous
Next →

Leave a Reply Cancel reply

You must be logged in to post a comment.

Recent Posts

Sollis Therapeutics Announces the First Patient Enrolled in a Phase 3 Clinical Trial of Clonidine Micropellet for Sciatica
Dr. Gregory Fiore to Participate in a Panel on Pain Management: Alternatives to Opioids at BioOhio’s Neuroscience Discovery & Alternatives to Opioids Event
Ohio State neurosurgeon’s startup could seek Third Frontier funds to reduce opioid prescriptions
State awards money to support technological solutions to fight opiates
Neurotechnology Innovations Translator (NIT) Announces Funding of up to $50 Million in Portfolio Company Sollis Therapeutics

Sollis Therapeutics
PO Box 450
Hilliard, OH 43026

Copyright © 2017-2022 Sollis All rights reserved.